Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Linagliptin + Metformin vs Metformin Alone on the Role of Pancreatic Islet Function, Insulin Resistance and Markers of Cardiovascular Risk in Patients With Prediabetes: Randomized Clinical Trial

NCT03004612 is registered in ClinicalTrials.gov with Universidad de Guanajuato as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03004612 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Linagliptin + Metformin vs Metformin Alone on the Role of Pancreatic Islet Function, Insulin Resistance and Markers of Cardiovascular Risk in Patients With Prediabetes: Randomized Clinical Trial
Lead sponsor
Universidad de Guanajuato
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2016
Completion date
June 30, 2019
Enrollment
144 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.